In orthotopic tumor models, systemic TNF alpha was sufficient to restore MHC-I expression on tumor cells and enhance response to ICI in mouse models, leading to tumor regression that was associated with lasting systemic anti-tumor immunity that prevented engraftment on repeated tumor challenge. This evidence concerns the gene TNF and neoplasm.